Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis

Published:2021-01 Issue:1 Volume:23 Page:25-36
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Büttner Stefan,Galjart Boris,Beumer Berend R.,van Vugt Jeroen L.A.,van Eijck Casper H.J.,Polak Wojciech G.,de Jonge Jeroen,Homs Marjolein Y.V.,van Driel Lydi M.J.W.,Pawlik Timothy M.,Steyerberg Ewout W.,Ijzermans Jan N.M.,Groot Koerkamp Bas

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference61 articles.

1. Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia;Shin;Asian Pac J Cancer Prev,2010

2. Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center;Singal;J Cancer Res Clin Oncol,2011

3. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas;Everhart;Gastroenterology,2009

4. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution;DeOliveira;Ann Surg,2007

5. Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone;Konstantinidis;Cancer,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of machine learning models for patients in the high intrahepatic cholangiocarcinoma incidence age group;BMC Geriatrics;2024-06-25

2. Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancers;Clinical and Translational Oncology;2024-03-26

3. Development and validation of the Baseline Recurrence Risk in Cellulitis (BRRISC) score;Journal of Infection;2024-02

4. Identification of FOXP1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma;BMC Cancer;2024-01-26

5. Translating imaging traits of mass-forming intrahepatic cholangiocarcinoma into the clinic: From prognostic to therapeutic insights;JHEP Reports;2023-10